Erlocip contains erlotinib and belongs to a class of medications called kinase inhibitors.
Indications:
Erlocip is used for the treatment of non-small cell lung cancer. Erlocip is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body.
Mechanism of Action: Erlocip works by blocking the action of an abnormal protein that slows the growth of cancer cells. This helps slow or stop the spread of cancer cells.
Supplied as: Erlocip is available as 150mg tablets.
Overdose: Symptoms of overdose associated with Erlocip may include diarrhea and rash.
Privacy Policy Important Notice! TradeHolding.com B2B Network does not provide an escrow service! Any member who asks you to pay for their products by Western Union to an agent of "TradeHolding.com B2B Network" is fraud and should be immediately reported to us. Do not pay anything to any member who states your money will be added to TradeHolding.com safety deposit account!
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and Middle East B2B Directory and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.
Trade Leads Directory -> All Trade Leads -> Health & Beauty -> Drugs & Medications -> Erlonat (250Mg) 
